Oxford Nanopore Technologies Ltd Market Cap ($24.48 Million)
Market Cap & Net Worth: Oxford Nanopore Technologies Ltd (ONT)
Oxford Nanopore Technologies Ltd market cap. Oxford Nanopore Technologies Ltd (LSE:ONT) has a market capitalization of $24.48 Million (GBX201.17 Billion) as of November 8, 2026. Listed on the LSE stock exchange, this UK-based company holds position #24263 globally and #232 in its home market, demonstrating a -11.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oxford Nanopore Technologies Ltd's stock price GBX205.80 by its total outstanding shares 977505204 (977.51 Million). Also see ONT operating cash flow for how efficiently the company converts equity into cash flow.
Oxford Nanopore Technologies Ltd Market Cap History (2021–2026)
Oxford Nanopore Technologies Ltd market cap history from 2021 to 2026. Data shows change from $83.02 Million to $24.48 Million (-19.24% CAGR). Check Oxford Nanopore Technologies Ltd share price for real-time trading data and today's change.
Oxford Nanopore Technologies Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oxford Nanopore Technologies Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Oxford Nanopore Technologies Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.07x
Oxford Nanopore Technologies Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $83.02 Million | $133.66 Million | -$167.61 Million | 0.62x | N/A |
| 2022 | $29.32 Million | $198.60 Million | -$91.03 Million | 0.15x | N/A |
| 2023 | $24.76 Million | $169.67 Million | -$154.51 Million | 0.15x | N/A |
| 2024 | $15.32 Million | $183.19 Million | -$146.19 Million | 0.08x | N/A |
| 2025 | $15.27 Million | $223.90 Million | -$145.20 Million | 0.07x | N/A |
Competitor Companies of ONT by Market Capitalization
Companies near Oxford Nanopore Technologies Ltd in the global market cap rankings as of November 8, 2026. Also see total assets of Oxford Nanopore Technologies Ltd for a full breakdown of the balance sheet.
Key companies related to Oxford Nanopore Technologies Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Oxford Nanopore Technologies Ltd (2021–2026)
Market capitalization of Oxford Nanopore Technologies Ltd from 2021 to today. Between 2021 and today, Oxford Nanopore Technologies Ltd's market cap moved from $83.02 Million to $ 24.48 Million, with a yearly change of -19.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX24.48 Million | +60.28% |
| 2025 | GBX15.27 Million | -0.31% |
| 2024 | GBX15.32 Million | -38.14% |
| 2023 | GBX24.76 Million | -15.54% |
| 2022 | GBX29.32 Million | -64.68% |
| 2021 | GBX83.02 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Oxford Nanopore Technologies Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.48 Million USD |
| MoneyControl | $24.48 Million USD |
| MarketWatch | $24.48 Million USD |
| marketcap.company | $24.48 Million USD |
| Reuters | $24.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more